{"ticker": {"uuid": "1f01406d-ae64-403d-a3ef-0eb344e3c3d9", "symbol": "HNSA", "name": "Hansa Biopharma AB (publ)", "exchange": "STO", "country": "SE", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Adrigo Small & Midcap L/S fell 5.0 percent in June, Hansa Biopharma and Braincool contributed the most positively", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxPMjhvS2lGWU1kdXRnN0lfSk5EQzI2ZE0zVm11ZGJNQXFtY2llVkxPVjdEalVOajFRMTdfWDF6My1kbElJeGZzSHE4bEE2dFpPcElSbVFZZ2l2WTQ3ajZsSHVhOTJieDY4QlFNTXRBWW1qRF9Wc0RXVng3OXJ1elExLTA0X3llVEVUMjRfaVpoWjZGaXRoYnZDZ2YwV3BETmlNQ1dQb00yTmxzQlhlOUJhMHdIRGo1TThWNUNFN19MYWZ6MXRaWlhuTXQ5aE1haHdJR0pHV2p2RE8wQlFVNzBTekcwZXI?oc=5", "source_name": "marketscreener.com", "published_at": "2026-07-09T11:13:31+00:00", "published_display": "09 Jul 2026 11:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hansa Biopharma to host Q2 2026 interim results conference call", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxOTktLV1BRZ1FSejd3aE1aczZFcGlCN2gySEFOWkZGQlI0UURhdnhGQkU2RlJqNkhtRnZzblZjLTI2ZDA5bjY3N1NjdmxhVnNLUWJKNDlHREUwb3Y4YWlJZzluZk50ck5KV2tDRmprU2lHZHJlZG9YVHRHd1JXSDNHdW5yQTR6Qk9YbjhOeW1hQ1BVbE55UWtjOTlvT242WnVmV2JWV0phVWdJT05UczJWTDdNajd3MkU?oc=5", "source_name": "marketscreener.com", "published_at": "2026-07-08T09:31:07+00:00", "published_display": "08 Jul 2026 09:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hansa Biopharma Announces Late-Breaking Abstract from ConfIdeS Phase 3 Trial Selected for Oral Presentation at ATC 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxQVlpzbzZncTdzckNXXzdDYk54NlJTbDRvMnBYVUQ4RHNpOFhLQVh2WkJScVFOYk5zQVZQM2UzMXhBNG9EWHRUUFZhVGt5X1FCUHgxSm9ZYTFZcXhMTGxWUUpaLU5RcFZLS0R4dFh5dXprTUprT0VocVowWHhxUmZQay14VHJfVzFuN0k1bG9JZGE?oc=5", "source_name": "AOL.com", "published_at": "2026-07-08T08:44:56+00:00", "published_display": "08 Jul 2026 08:44", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hansa Biopharma\u2019s Maria T\u00f6rns\u00e9n speaks at renal summit July 8", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxPOGhQdzl4MGZ3SVc2bUY4SVl3cEZKNVl1c1dLOWRsd1ZXZkxaTjFzLXZkUE53MU9ZaG9vTUlNZWZmbnBuRkpqNFRUSFZwY3NycUhRVVJ5VGExZTRkUmU5UUZ4VEE1RGdnTkgwMlJEYnRBQlRxdlJ2QktCVVBTT1ZCdHZSWWVVZC13cVhUb21DeUwzSllselUtNTZVeXd5QXVmcVdqb0hQUE5BQUJZRW93?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hansa hands SERB Europe and MENA rights to Idefirix in \u20ac115M deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxNcjdDdG44STQxTUJTMmJMSmVpRE5CRkJVbUFRYUxuNDFTU1pYRFVRQmk5SGlpbzBranh3TkdxSkJTQzlrWDU5d2ZIWVdzUXBLbGRicGh0Qmx4VHNRV3dla2FkZ2trSno2Q2xsekFKRHlmLWVuOU5KUS1UMzBaVEhvQ05YMnBKbEdVOTBJOXhEc3hfb09SVXpheU56WElUY2VqaVAwVEg1d05sRWlqWUllNHBuQQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hansa Biopharma Names Veteran Biotech Executive Adam Cutler as New CFO", "summary": "", "url": "https://news.google.com/rss/articles/CBMi7AFBVV95cUxOYlNxdDNoY3oyR0pxb0xDWDJTOENUUFVWeFc1ajNCWXQxNGJQMEZTc0w3YWcyejB1bm9iQmg1MTNsRXBjSllXU1pNMVpFWmpBQXNmd0tVRGhmSms1TzI4bUNWQnphRnpGRVlOQ004c3hPWGhDWkxsQ3hXYTFCdmlWWHpHSk5LSkxKSWJvZ2E5Qkh2M05KR2U0aVFDQ2hhYzVtNG9TanZ0eF93bUZtSUJiUGZVR3dNZDhCemd3M01OVmxsdnN4dzJraVNaNVVtckt3eF9jNURpTHR1QW5lWHRiQlZ5ZElza3JzSXgzTA?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hansa Biopharma invite to Capital Markets Day 2026 in New York", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxNRGdXZGtPSXlHTFJrU0MteDd0NFRoSENxTzEwMDVqTVZSY2hIZVFpdjhLdEZQN3gwb2p5RjVSTmh4N09HUDlWeHhkdGNxeDNra3B6elR2RHdLdlJMV0pvcE9pOHRlekJ5LTg5TDlhNUhhZjFzWTdFVWNfbnpyWlg1OGpqODE5eG9yMVlkZHI2dDNFREhSUFFrZGk3OGZHVjhVSTlrUS1BY3Z6TXZLQ0EzVW81amZtdw?oc=5", "source_name": "marketscreener.com", "published_at": "2026-06-12T07:00:00+00:00", "published_display": "12 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hansa Biopharma appoints Head of Business Development from AstraZeneca", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxOaU9rd2pVWld4TTA2MVhTUjQxcXpFeDJhVjhpdmlWTnZFYzB1TFhSYkQwd01sUkRReU5KT2ZVZXJXMGxNVU9nNjJjZXhXNjZLR1AzVzBMaFZXb2RZaVdwanpDcFVidzJmSWowNmFOU2ZqWWdraFg5MXBmRnUxQzZuc19HMlFLMUJWUEdRQjFrUzI5WUV1QlQ3VHFZTWRVVGxCVnZVYTRFbWRNb3IyWHhWbUFQWGtOTUlnU3NmRTZrMmo?oc=5", "source_name": "marketscreener.com", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hansa Biopharma participating in Jefferies Global Healthcare Conference in New York", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxPX1p2SnlNX1g1SE5oNS03a2ZIRUJjcjBSQWhxUmlWaEtiMFM1XzM5YTVrcmtFRFRGWVJjUFN2SFhDcWl1TllvVnBPVlRNdE1NSUlvRWNCZldkZ2NxY1EzdXRfd3lFTnppandsY1lxWHpTR3EyMmdzQzBLRVVZU2c4SWhtT1Z3VXMwT05WWGR3LU85UTJTUHptM2lLR3VKSUpqWkd5NEJyaXhLSmVyUEpjNnVYNjhjSTdWOFV0Z0ExT2JzbTJUWmFNczBFYUp3YXFhekE?oc=5", "source_name": "marketscreener.com", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Analysts Just Made A Massive Upgrade To Their Hansa Biopharma AB (publ) (STO:HNSA) Forecasts", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hansa Biopharma trial results to be presented at ATC in June", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNX21KejJoOVR5ejlWNkhMSEpvMlhvUHZha0gtRUtLTExfTS1QeFdLbWlHUE1aUDBWTC1COVVpQkstWC10czkwWFBTN1lXQThscmE2SDVoRzJnaWtSVktPSUx1UC0yNUNidWtHN2V2SFBuUVp1QjZhRzYzbE1mWXNNYzdZTWxRVzNCdVJfUzlWcGZCNllkNGdfUVBYcnZpQzhZLU4tcEZwQ1VSdDE0cHV0UEpZQ2M0M0lpTy1JUGFB?oc=5", "source_name": "Investing.com Nigeria", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sweden's Hansa strikes $134 million deal with SERB for kidney drug", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxNbUR5S0NjdjhpYVdGZlg0eF93NFlCc2hta0ZOa0kySnFSYVhBQ24tQ1Exb0lmblpGLXJqMEVGaW12aEtBNC00ZVl5RElLd25pdzFkVXpUV19LenRBeGc2QjVFMTFSVFM4eDhaT3FtZ3U3bHdMUFBXY2MwTmxzaGxzYnJISFg4d2VxcllLLWJHMDNSNk1FU2NJS2E4UWFrSFhnN21naE5yVjlXck81VTdiSnRkRQ?oc=5", "source_name": "Reuters", "published_at": "2026-05-19T07:00:00+00:00", "published_display": "19 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hansa Biopharma (OM:HNSA) Heavy Net Loss Tests Bullish Revenue Growth Narrative", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-04-24T07:00:00+00:00", "published_display": "24 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings call transcript: Hansa Biopharma Q3 2025 revenue drops 37%, stock tumbles", "summary": "", "url": "https://news.google.com/rss/articles/CBMizwFBVV95cUxNcGlGcTdiTE9UazBvWUsxd1AxWXp3ZWNyNlp2S0FRczVzdkUxZTlWRXdsTms2ME9jczB5NmNiaFh5Qm55VjdPdExvbnZjYXotS01wMlpoT25VNHZUU2NBWExSWDVoTTREbWNGWXVKOXd3RW44UFBWOHRnc0JVVThLdlVIWGk4U3dtQzBEeGVuT2Y1X0VFeHQ3TGR1aXJRTFpUTHFhVWp2NnNUVWZvTXBGMzltMnlHVXRvTjdMZ2xuc2Z2dVNKaW5Ic3ZJLWxTWDA?oc=5", "source_name": "Investing.com UK", "published_at": "2025-10-30T07:00:00+00:00", "published_display": "30 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hansa Medical AB (HNSBF) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiVEFVX3lxTFBERjJxOS1OVV81a29xUXBrdDItMDczSDJEdWlfUUJRbUxzOWtkSG9jNXNuNkNyOHNsdzVydXNPZThiWU02azVOSmU2UDgyLV90N0JwRQ?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-25T00:44:45+00:00", "published_display": "25 Apr 2025 00:44", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hansa Biopharma AB: Target Price Consensus and Analysts Recommendations | HNSA | SE0002148817", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxPbm4zOVhHSlhfajNGRXdqYzhfd3U5d2pXUThHVkdwUGozOHZGM2lCMktEOTFyTllRTVlSckM5ZTNaQU81TGhTdzkzcHZ0NzlLSGtfR3NaeXZrOFEydnR4dlFkUkF1TDNXUGpGQ2tlYUxlb1Z5Wlk3dE90N1otdkU1X3VaYXNtYjNM?oc=5", "source_name": "marketscreener.com", "published_at": "2024-01-24T04:23:25+00:00", "published_display": "24 Jan 2024 04:23", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Technical Analysis of Hansa Biopharma AB (OMXSTO:HNSA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMia0FVX3lxTE92amNxa3drV2JEZHJOYnNmSERKczNhdEtEOWZkeFhpbVBLcUdWenM0SDROQm5JS0lqRTNYMVRvWThtNFNZZmNoTE1zWldOdHFXaEVGekNkTElvLWx1ZEExZzZ0X1hCUEluZkY0?oc=5", "source_name": "TradingView", "published_at": "2019-01-07T00:02:02+00:00", "published_display": "07 Jan 2019 00:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Adrigo Small & Midcap L/S fell 5.0 percent in June, Hansa Biopharma and Braincool contributed the most positively", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxPMjhvS2lGWU1kdXRnN0lfSk5EQzI2ZE0zVm11ZGJNQXFtY2llVkxPVjdEalVOajFRMTdfWDF6My1kbElJeGZzSHE4bEE2dFpPcElSbVFZZ2l2WTQ3ajZsSHVhOTJieDY4QlFNTXRBWW1qRF9Wc0RXVng3OXJ1elExLTA0X3llVEVUMjRfaVpoWjZGaXRoYnZDZ2YwV3BETmlNQ1dQb00yTmxzQlhlOUJhMHdIRGo1TThWNUNFN19MYWZ6MXRaWlhuTXQ5aE1haHdJR0pHV2p2RE8wQlFVNzBTekcwZXI?oc=5", "source_name": "marketscreener.com", "published_at": "2026-07-09T11:13:31+00:00", "published_display": "09 Jul 2026 11:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hansa Biopharma to host Q2 2026 interim results conference call", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxOTktLV1BRZ1FSejd3aE1aczZFcGlCN2gySEFOWkZGQlI0UURhdnhGQkU2RlJqNkhtRnZzblZjLTI2ZDA5bjY3N1NjdmxhVnNLUWJKNDlHREUwb3Y4YWlJZzluZk50ck5KV2tDRmprU2lHZHJlZG9YVHRHd1JXSDNHdW5yQTR6Qk9YbjhOeW1hQ1BVbE55UWtjOTlvT242WnVmV2JWV0phVWdJT05UczJWTDdNajd3MkU?oc=5", "source_name": "marketscreener.com", "published_at": "2026-07-08T09:31:07+00:00", "published_display": "08 Jul 2026 09:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hansa Biopharma Announces Late-Breaking Abstract from ConfIdeS Phase 3 Trial Selected for Oral Presentation at ATC 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxQVlpzbzZncTdzckNXXzdDYk54NlJTbDRvMnBYVUQ4RHNpOFhLQVh2WkJScVFOYk5zQVZQM2UzMXhBNG9EWHRUUFZhVGt5X1FCUHgxSm9ZYTFZcXhMTGxWUUpaLU5RcFZLS0R4dFh5dXprTUprT0VocVowWHhxUmZQay14VHJfVzFuN0k1bG9JZGE?oc=5", "source_name": "AOL.com", "published_at": "2026-07-08T08:44:56+00:00", "published_display": "08 Jul 2026 08:44", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hansa Biopharma\u2019s Maria T\u00f6rns\u00e9n speaks at renal summit July 8", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxPOGhQdzl4MGZ3SVc2bUY4SVl3cEZKNVl1c1dLOWRsd1ZXZkxaTjFzLXZkUE53MU9ZaG9vTUlNZWZmbnBuRkpqNFRUSFZwY3NycUhRVVJ5VGExZTRkUmU5UUZ4VEE1RGdnTkgwMlJEYnRBQlRxdlJ2QktCVVBTT1ZCdHZSWWVVZC13cVhUb21DeUwzSllselUtNTZVeXd5QXVmcVdqb0hQUE5BQUJZRW93?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hansa hands SERB Europe and MENA rights to Idefirix in \u20ac115M deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxNcjdDdG44STQxTUJTMmJMSmVpRE5CRkJVbUFRYUxuNDFTU1pYRFVRQmk5SGlpbzBranh3TkdxSkJTQzlrWDU5d2ZIWVdzUXBLbGRicGh0Qmx4VHNRV3dla2FkZ2trSno2Q2xsekFKRHlmLWVuOU5KUS1UMzBaVEhvQ05YMnBKbEdVOTBJOXhEc3hfb09SVXpheU56WElUY2VqaVAwVEg1d05sRWlqWUllNHBuQQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hansa Biopharma Names Veteran Biotech Executive Adam Cutler as New CFO", "summary": "", "url": "https://news.google.com/rss/articles/CBMi7AFBVV95cUxOYlNxdDNoY3oyR0pxb0xDWDJTOENUUFVWeFc1ajNCWXQxNGJQMEZTc0w3YWcyejB1bm9iQmg1MTNsRXBjSllXU1pNMVpFWmpBQXNmd0tVRGhmSms1TzI4bUNWQnphRnpGRVlOQ004c3hPWGhDWkxsQ3hXYTFCdmlWWHpHSk5LSkxKSWJvZ2E5Qkh2M05KR2U0aVFDQ2hhYzVtNG9TanZ0eF93bUZtSUJiUGZVR3dNZDhCemd3M01OVmxsdnN4dzJraVNaNVVtckt3eF9jNURpTHR1QW5lWHRiQlZ5ZElza3JzSXgzTA?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hansa Biopharma invite to Capital Markets Day 2026 in New York", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxNRGdXZGtPSXlHTFJrU0MteDd0NFRoSENxTzEwMDVqTVZSY2hIZVFpdjhLdEZQN3gwb2p5RjVSTmh4N09HUDlWeHhkdGNxeDNra3B6elR2RHdLdlJMV0pvcE9pOHRlekJ5LTg5TDlhNUhhZjFzWTdFVWNfbnpyWlg1OGpqODE5eG9yMVlkZHI2dDNFREhSUFFrZGk3OGZHVjhVSTlrUS1BY3Z6TXZLQ0EzVW81amZtdw?oc=5", "source_name": "marketscreener.com", "published_at": "2026-06-12T07:00:00+00:00", "published_display": "12 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hansa Biopharma appoints Head of Business Development from AstraZeneca", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxOaU9rd2pVWld4TTA2MVhTUjQxcXpFeDJhVjhpdmlWTnZFYzB1TFhSYkQwd01sUkRReU5KT2ZVZXJXMGxNVU9nNjJjZXhXNjZLR1AzVzBMaFZXb2RZaVdwanpDcFVidzJmSWowNmFOU2ZqWWdraFg5MXBmRnUxQzZuc19HMlFLMUJWUEdRQjFrUzI5WUV1QlQ3VHFZTWRVVGxCVnZVYTRFbWRNb3IyWHhWbUFQWGtOTUlnU3NmRTZrMmo?oc=5", "source_name": "marketscreener.com", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hansa Biopharma participating in Jefferies Global Healthcare Conference in New York", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxPX1p2SnlNX1g1SE5oNS03a2ZIRUJjcjBSQWhxUmlWaEtiMFM1XzM5YTVrcmtFRFRGWVJjUFN2SFhDcWl1TllvVnBPVlRNdE1NSUlvRWNCZldkZ2NxY1EzdXRfd3lFTnppandsY1lxWHpTR3EyMmdzQzBLRVVZU2c4SWhtT1Z3VXMwT05WWGR3LU85UTJTUHptM2lLR3VKSUpqWkd5NEJyaXhLSmVyUEpjNnVYNjhjSTdWOFV0Z0ExT2JzbTJUWmFNczBFYUp3YXFhekE?oc=5", "source_name": "marketscreener.com", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Analysts Just Made A Massive Upgrade To Their Hansa Biopharma AB (publ) (STO:HNSA) Forecasts", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hansa Biopharma trial results to be presented at ATC in June", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNX21KejJoOVR5ejlWNkhMSEpvMlhvUHZha0gtRUtLTExfTS1QeFdLbWlHUE1aUDBWTC1COVVpQkstWC10czkwWFBTN1lXQThscmE2SDVoRzJnaWtSVktPSUx1UC0yNUNidWtHN2V2SFBuUVp1QjZhRzYzbE1mWXNNYzdZTWxRVzNCdVJfUzlWcGZCNllkNGdfUVBYcnZpQzhZLU4tcEZwQ1VSdDE0cHV0UEpZQ2M0M0lpTy1JUGFB?oc=5", "source_name": "Investing.com Nigeria", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sweden's Hansa strikes $134 million deal with SERB for kidney drug", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxNbUR5S0NjdjhpYVdGZlg0eF93NFlCc2hta0ZOa0kySnFSYVhBQ24tQ1Exb0lmblpGLXJqMEVGaW12aEtBNC00ZVl5RElLd25pdzFkVXpUV19LenRBeGc2QjVFMTFSVFM4eDhaT3FtZ3U3bHdMUFBXY2MwTmxzaGxzYnJISFg4d2VxcllLLWJHMDNSNk1FU2NJS2E4UWFrSFhnN21naE5yVjlXck81VTdiSnRkRQ?oc=5", "source_name": "Reuters", "published_at": "2026-05-19T07:00:00+00:00", "published_display": "19 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hansa Biopharma (OM:HNSA) Heavy Net Loss Tests Bullish Revenue Growth Narrative", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-04-24T07:00:00+00:00", "published_display": "24 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings call transcript: Hansa Biopharma Q3 2025 revenue drops 37%, stock tumbles", "summary": "", "url": "https://news.google.com/rss/articles/CBMizwFBVV95cUxNcGlGcTdiTE9UazBvWUsxd1AxWXp3ZWNyNlp2S0FRczVzdkUxZTlWRXdsTms2ME9jczB5NmNiaFh5Qm55VjdPdExvbnZjYXotS01wMlpoT25VNHZUU2NBWExSWDVoTTREbWNGWXVKOXd3RW44UFBWOHRnc0JVVThLdlVIWGk4U3dtQzBEeGVuT2Y1X0VFeHQ3TGR1aXJRTFpUTHFhVWp2NnNUVWZvTXBGMzltMnlHVXRvTjdMZ2xuc2Z2dVNKaW5Ic3ZJLWxTWDA?oc=5", "source_name": "Investing.com UK", "published_at": "2025-10-30T07:00:00+00:00", "published_display": "30 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hansa Medical AB (HNSBF) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiVEFVX3lxTFBERjJxOS1OVV81a29xUXBrdDItMDczSDJEdWlfUUJRbUxzOWtkSG9jNXNuNkNyOHNsdzVydXNPZThiWU02azVOSmU2UDgyLV90N0JwRQ?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-25T00:44:45+00:00", "published_display": "25 Apr 2025 00:44", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hansa Biopharma AB: Target Price Consensus and Analysts Recommendations | HNSA | SE0002148817", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxPbm4zOVhHSlhfajNGRXdqYzhfd3U5d2pXUThHVkdwUGozOHZGM2lCMktEOTFyTllRTVlSckM5ZTNaQU81TGhTdzkzcHZ0NzlLSGtfR3NaeXZrOFEydnR4dlFkUkF1TDNXUGpGQ2tlYUxlb1Z5Wlk3dE90N1otdkU1X3VaYXNtYjNM?oc=5", "source_name": "marketscreener.com", "published_at": "2024-01-24T04:23:25+00:00", "published_display": "24 Jan 2024 04:23", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Technical Analysis of Hansa Biopharma AB (OMXSTO:HNSA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMia0FVX3lxTE92amNxa3drV2JEZHJOYnNmSERKczNhdEtEOWZkeFhpbVBLcUdWenM0SDROQm5JS0lqRTNYMVRvWThtNFNZZmNoTE1zWldOdHFXaEVGekNkTElvLWx1ZEExZzZ0X1hCUEluZkY0?oc=5", "source_name": "TradingView", "published_at": "2019-01-07T00:02:02+00:00", "published_display": "07 Jan 2019 00:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 69, "total_relevant": 17, "sentiment_summary": {"positive": 2, "negative": 0, "neutral": 15, "score": 52, "total": 17, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 78, "events": [{"event": "general", "label": "Market update", "weight": 4.95, "count": 9}, {"event": "earnings", "label": "Earnings", "weight": 2.2, "count": 4}, {"event": "deals", "label": "Deals and strategy", "weight": 1.45, "count": 2}, {"event": "analyst", "label": "Analyst action", "weight": 1.1, "count": 2}], "positive_events": 2, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 34.16, "latest_week": "2026-07-10", "one_week_move": -2.1, "four_week_move": -0.9, "twelve_week_move": 17.6, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.564497, "market_dynamics_buy_signal": false, "relative_strength": -2.984558, "fair_value_gap": 3.2, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "negative", "expectation_probability": 42.0877, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-2.1% over one week, -0.9% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 60, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "marketscreener.com", "count": 6}, {"label": "Stock Titan", "count": 3}, {"label": "simplywall.st", "count": 2}, {"label": "AOL.com", "count": 1}, {"label": "The Globe and Mail", "count": 1}, {"label": "Investing.com Nigeria", "count": 1}, {"label": "Reuters", "count": 1}, {"label": "Investing.com UK", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 17}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 9}, {"label": "Earnings", "count": 4}, {"label": "Deals and strategy", "count": 2}, {"label": "Analyst action", "count": 2}]}, "insights": [{"label": "Weighted tone", "value": "52/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "78/100 classification confidence."}, {"label": "Company focus", "value": "17", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-2.1% over one week, -0.9% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Adrigo Small & Midcap L/S fell 5.0 percent in June, Hansa Biopharma and Braincool contributed the most positively"}], "updated_at": "2026-07-17T18:36:14.182973+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}